CEFTAZIDIME Drug Patent Profile
✉ Email this page to a colleague
When do Ceftazidime patents expire, and when can generic versions of Ceftazidime launch?
Ceftazidime is a drug marketed by Acs Dobfar, Aurobindo Pharma Ltd, Wockhardt, B Braun, and Baxter Hlthcare. and is included in six NDAs.
The generic ingredient in CEFTAZIDIME is ceftazidime sodium. There are seventeen drug master file entries for this compound. Additional details are available on the ceftazidime sodium profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CEFTAZIDIME?
- What are the global sales for CEFTAZIDIME?
- What is Average Wholesale Price for CEFTAZIDIME?
Summary for CEFTAZIDIME
| US Patents: | 0 |
| Applicants: | 5 |
| NDAs: | 6 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 42 |
| Clinical Trials: | 68 |
| Patent Applications: | 6,623 |
| Drug Prices: | Drug price information for CEFTAZIDIME |
| DailyMed Link: | CEFTAZIDIME at DailyMed |
Recent Clinical Trials for CEFTAZIDIME
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Tata Memorial Centre | Phase 2 |
| Qianfoshan Hospital | N/A |
| Arrevus Inc. | Phase 2 |
Pharmacology for CEFTAZIDIME
| Drug Class | Cephalosporin Antibacterial |
Medical Subject Heading (MeSH) Categories for CEFTAZIDIME
Anatomical Therapeutic Chemical (ATC) Classes for CEFTAZIDIME
US Patents and Regulatory Information for CEFTAZIDIME
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Acs Dobfar | CEFTAZIDIME | ceftazidime | INJECTABLE;INJECTION | 062640-002 | Nov 20, 1985 | AP | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Aurobindo Pharma Ltd | CEFTAZIDIME | ceftazidime | INJECTABLE;INJECTION | 065482-001 | May 28, 2010 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Acs Dobfar | CEFTAZIDIME | ceftazidime | INJECTABLE;INJECTION | 062640-001 | Nov 20, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Baxter Hlthcare | CEFTAZIDIME SODIUM IN PLASTIC CONTAINER | ceftazidime sodium | INJECTABLE;INJECTION | 063221-001 | Apr 29, 1993 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Aurobindo Pharma Ltd | CEFTAZIDIME | ceftazidime | INJECTABLE;INJECTION | 065481-001 | May 28, 2010 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
